Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$1.4B |
| 2 |
ExxonMobil
XOM
|
+$1.39B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$932M |
| 4 |
Procter & Gamble
PG
|
+$925M |
| 5 |
Walmart Inc
WMT
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$1.66B |
| 2 |
Salesforce
CRM
|
+$1.17B |
| 3 |
Lam Research
LRCX
|
+$974M |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$972M |
| 5 |
Applied Materials
AMAT
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.72% |
| 2 | Financials | 12.27% |
| 3 | Healthcare | 10.07% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
WEX
WEX
$6.31B
| $5.23M | ﹤0.01% |
22,010
+4,832
| +28% | +$1.04M |
|
502
Celldex Therapeutics
CLDX
$3.28B
| $5.2M | ﹤0.01% |
123,836
+102,024
| +468% | +$4.19M |
|
503
NNN REIT
NNN
$8.99B
| $5.09M | ﹤0.01% |
119,188
+108
| +0.1% | +$4.49K |
|
504
Chemed
CHE
$7.22B
| $5.02M | ﹤0.01% |
7,813
-7
| -0.1% | -$4.25K |
|
505
Broadstone Net Lease
BNL
$4.02B
| $4.98M | ﹤0.01% |
318,032
| – | – |
|
506
Vicor
VICR
$10.2B
| $4.98M | ﹤0.01% |
130,280
+5,961
| +5% | +$232K |
|
507
ResMed
RMD
$30.7B
| $4.81M | ﹤0.01% |
24,267
+1,416
| +6% | +$259K |
|
508
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| $4.78M | ﹤0.01% |
92,545
+8,468
| +10% | +$435K |
|
509
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
| $4.49M | ﹤0.01% |
17,265
-2,107
| -11% | -$521K |
|
510
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.51B
| $4.47M | ﹤0.01% |
28,852
+238
| +0.8% | +$33K |
|
511
Global Net Lease
GNL
$1.95B
| $4.44M | ﹤0.01% |
571,604
-8,666
| -1% | -$71.1K |
|
512
CBRE Group
CBRE
$42.9B
| $4.29M | ﹤0.01% |
44,167
+102
| +0.2% | +$9.16K |
|
513
Roper Technologies
ROP
$39.8B
| $4.25M | ﹤0.01% |
7,583
-671
| -8% | -$366K |
|
514
Moelis & Co
MC
$4.94B
| $4.22M | ﹤0.01% |
74,378
+7,013
| +10% | +$383K |
|
515
Box
BOX
$4.6B
| $4.17M | ﹤0.01% |
147,421
+4,059
| +3% | +$109K |
|
|
RYZ
516
Ryerson Holding Corp
RYZ
$1.46B
| $4.12M | ﹤0.01% |
123,019
-3,654
| -3% | -$120K |
|
517
Clorox
CLX
$12.7B
| $4.11M | ﹤0.01% |
26,860
+3,894
| +17% | +$581K |
|
|
K
518
DELISTED
Kellanova
K
| $4.08M | ﹤0.01% |
71,154
+7,359
| +12% | +$405K |
|
519
Campbell Soup
CPB
$6.87B
| $3.98M | ﹤0.01% |
89,430
+4,286
| +5% | +$185K |
|
520
Revvity
RVTY
$12.8B
| $3.95M | ﹤0.01% |
37,576
+373
| +1% | +$39.7K |
|
521
Ligand Pharmaceuticals
LGND
$6.36B
| $3.9M | ﹤0.01% |
53,377
+4,080
| +8% | +$301K |
|
522
Stellantis
STLA
$20.8B
| $3.88M | ﹤0.01% |
137,143
+4,229
| +3% | +$105K |
|
|
POWR
523
iShares U.S. Power Infrastructure ETF
POWR
$458M
| $3.87M | ﹤0.01% |
146,108
+4,409
| +3% | +$108K |
|
524
FormFactor
FORM
$9.17B
| $3.86M | ﹤0.01% |
84,590
-8,124
| -9% | -$338K |
|
525
AptarGroup
ATR
$8.61B
| $3.86M | ﹤0.01% |
26,806
-3,462
| -11% | -$469K |
|
Similar funds
Ken Fisher's Q1 2024 Portfolio in Review
As of Q1 2024, Ken Fisher held 1,068 positions worth $214B, up 13% from $189B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2024 filing shows 87 new, 392 increased, 448 reduced and 104 closed positions. Its largest new stake was Nomura Holdings: 8,478,338 shares worth $54.4M. The largest sale was ASML, an estimated $1.66B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q1 2024 buy was Nomura Holdings: 8,478,338 shares worth $54.4M.
- Ken Fisher added most to Chevron in Q1 2024, an estimated $1.4B increase.
- Ken Fisher's biggest Q1 2024 reduction was ASML, cutting an estimated $1.66B.
- Ken Fisher fully exited Veradigm Inc. Common Stock in Q1 2024, selling an estimated $23.8M.
- Ken Fisher's ten largest holdings make up 31% of its $214B portfolio in Q1 2024.
- Ken Fisher opened 87 new positions and closed 104 in Q1 2024.
- Ken Fisher's portfolio value rose 13% quarter-over-quarter to $214B.
Based on Fisher Asset Management's 13F filing for Q1 2024, filed 9 May 2024.